Literature DB >> 10566758

Subacute severe steatohepatitis during prednisolone therapy for systemic lupus erythematosis.

T Nanki, R Koike, N Miyasaka.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10566758     DOI: 10.1111/j.1572-0241.1999.03379.x

Source DB:  PubMed          Journal:  Am J Gastroenterol        ISSN: 0002-9270            Impact factor:   10.864


× No keyword cloud information.
  14 in total

Review 1.  Acute liver damage following intravenous glucocorticoid treatment for Graves' ophthalmopathy.

Authors:  Mariacarla Moleti; Giuseppe Giuffrida; Giacomo Sturniolo; Giovanni Squadrito; Alfredo Campennì; Silvia Morelli; Efisio Puxeddu; Eleonora Sisti; Francesco Trimarchi; Francesco Vermiglio; Michele Marinò
Journal:  Endocrine       Date:  2016-03-22       Impact factor: 3.633

2.  Autoimmune hepatitis during intravenous glucocorticoid pulse therapy for Graves' ophthalmopathy treated successfully with glucocorticoids themselves.

Authors:  M Marinò; E Morabito; M A Altea; E Ambrogini; F Oliveri; M R Brunetto; L E Pollina; D Campani; P Vitti; L Bartalena; A Pincheral; C Marcocci
Journal:  J Endocrinol Invest       Date:  2005-03       Impact factor: 4.256

3.  Aggressive non-alcoholic steatohepatitis following rapid weight loss and/or malnutrition.

Authors:  Jia-Huei Tsai; Linda D Ferrell; Vivian Tan; Matthew M Yeh; Monika Sarkar; Ryan M Gill
Journal:  Mod Pathol       Date:  2017-03-03       Impact factor: 7.842

Review 4.  Mechanisms of glucocorticoid-induced insulin resistance: focus on adipose tissue function and lipid metabolism.

Authors:  Eliza B Geer; Julie Islam; Christoph Buettner
Journal:  Endocrinol Metab Clin North Am       Date:  2014-03       Impact factor: 4.741

5.  Liver injury induced by high-dose methylprednisolone therapy: a case report and brief review of the literature.

Authors:  Krzysztof Gutkowski; Alina Chwist; Marek Hartleb
Journal:  Hepat Mon       Date:  2011-08       Impact factor: 0.660

6.  Histological Remission during Corticosteroid Therapy of Overlapping Nonalcoholic Steatohepatitis and Autoimmune Hepatitis: Case Report and Literature Review.

Authors:  Shinichiroh Fukuda; Atsumasa Komori; Masahiro Itoh; Yumi Mihara; Satoru Hashimoto; Sung Kwan Bae; Shinya Nagaoka; Seigo Abiru; Hiroshi Yatsuhashi; Hiromi Ishibashi
Journal:  Case Rep Gastroenterol       Date:  2011-09-16

7.  Case report: hexachloroethane smoke inhalation: a rare cause of severe hepatic injuries.

Authors:  Ching-Hui Loh; Yaw-Wen Chang; Saou-Hsing Liou; Jun-Hei Chang; Hong-I Chen
Journal:  Environ Health Perspect       Date:  2006-05       Impact factor: 9.031

8.  The role of glucocorticoid action in the pathophysiology of the Metabolic Syndrome.

Authors:  Minghan Wang
Journal:  Nutr Metab (Lond)       Date:  2005-02-02       Impact factor: 4.169

9.  Acute steatohepatitis, due to extreme metabolic dysregulation, as the first presentation of non-alcoholic fatty liver disease.

Authors:  Georgios Kranidiotis; Angeliki Angelidi; Emmanouel Sevdalis; Thomas-Nikolaos Telios; Alexandra Gougoutsi; Andreas Melidonis
Journal:  Clin Pract       Date:  2013-05-20

10.  A switch in hepatic cortisol metabolism across the spectrum of non alcoholic fatty liver disease.

Authors:  Adeeba Ahmed; Elizabeth Rabbitt; Theresa Brady; Claire Brown; Peter Guest; Iwona J Bujalska; Craig Doig; Philip N Newsome; Stefan Hubscher; Elwyn Elias; David H Adams; Jeremy W Tomlinson; Paul M Stewart
Journal:  PLoS One       Date:  2012-02-20       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.